TransWorldNews Current Releases http://www.transworldnews.com TransWorldNews Bringing Your News to the World Copyright TransWorldNews, Inc. RSSEngine 1.0.0.3 Sun, 19 May 2013 11:51:74 GMT 15 Current Releases http://www.transworldnews.com/images/twn_logo.gif http://www.transworldnews.com NeoPharm, Inc. Announces PRECISE Trial Update NeoPharm, Inc. (Nasdaq:NEOL) today announced that the independent Data Monitoring Committee ("DMC"), responsible for overseeing the Company's IL13-PE38QQR (cintredekin besudotox) Pivotal Phase III PRECISE trial for the treatment of Glioblastoma M ... http://www.transworldnews.com/NewsStory.aspx?storyid=3580 http://www.transworldnews.com/NewsStory.aspx?storyid=3580 Tue, 27 Dec 2005 13:07:20 GMT NeoPharm Announces Completion of PRECISE Trial Enrollment as Per Special Protocol Assessment Agreement NeoPharm, Inc. (Nasdaq:NEOL) today announced that it has received notification that the Company's cintredekin besudotox (IL13-PE38QQR) Pivotal Phase III PRECISE trial for the treatment of Glioblastoma Multiforme (GBM), the most aggressive form of ... http://www.transworldnews.com/NewsStory.aspx?storyid=3671 http://www.transworldnews.com/NewsStory.aspx?storyid=3671 Fri, 09 Dec 2005 06:00:00 GMT NeoPharm to Present at First Albany Capital Annual Growth Conference NeoPharm, Inc. (Nasdaq:NEOL) announced today that it has been invited to present at the First Albany Capital Annual Growth Conference scheduled for December 6-7, 2005. http://www.transworldnews.com/NewsStory.aspx?storyid=3672 http://www.transworldnews.com/NewsStory.aspx?storyid=3672 Wed, 30 Nov 2005 06:00:00 GMT NeoPharm Announces Precise Trial Update NeoPharm (Nasdaq:NEOL) today announced that it has received notification that the Company's cintredekin besudotox (IL13-PE38QQR) Pivotal Phase III PRECISE trial for the treatment of Glioblastoma Multiforme (GBM), the most aggressive form of brain ... http://www.transworldnews.com/NewsStory.aspx?storyid=3674 http://www.transworldnews.com/NewsStory.aspx?storyid=3674 Mon, 21 Nov 2005 06:00:00 GMT NeoPharm Investigators Present Preliminary LErafAON-ETU Phase I Data at AACR-NCI-EORTC International Conference NeoPharm, Inc. (Nasdaq:NEOL) today announced the presentation of preliminary Phase I results of the Company's NeoLipid(R) formulation of c-raf Antisense Oligonucleotide at the American Association of Cancer Research (AACR) - National Cancer Insti ... http://www.transworldnews.com/NewsStory.aspx?storyid=3675 http://www.transworldnews.com/NewsStory.aspx?storyid=3675 Tue, 15 Nov 2005 06:00:00 GMT NeoPharm Announces September 30, 2005 Financial Results NeoPharm, Inc. (Nasdaq:NEOL) today announced financial results for the third quarter and first nine months ended September 30, 2005. http://www.transworldnews.com/NewsStory.aspx?storyid=3676 http://www.transworldnews.com/NewsStory.aspx?storyid=3676 Tue, 01 Nov 2005 06:00:00 GMT NeoPharm Announces Appointment of Guillermo A. Herrera, Pharmaceutical Industry Executive, as President, Chief Executive Officer and Director NeoPharm, Inc. (Nasdaq:NEOL) today announced that on October 28, 2005, its Board of Directors unanimously appointed Guillermo A. Herrera, 52, as the Company's President and Chief Executive Officer. http://www.transworldnews.com/NewsStory.aspx?storyid=3677 http://www.transworldnews.com/NewsStory.aspx?storyid=3677 Mon, 31 Oct 2005 06:00:00 GMT NeoPharm Sets Conference Call and Webcast for Third Quarter 2005 Corporate Results NeoPharm, Inc. (Nasdaq:NEOL) today announced the date and time for its regularly-scheduled quarterly conference call to discuss corporate developments and financial highlights for the third quarter ended September 30, 2005. http://www.transworldnews.com/NewsStory.aspx?storyid=3678 http://www.transworldnews.com/NewsStory.aspx?storyid=3678 Tue, 18 Oct 2005 06:00:00 GMT NeoPharm Investigators Present Preliminary Phase I Data of Cintredekin Besudotox in the Treatment of Malignant Glioma at Initial Diagnosis NeoPharm, Inc. (Nasdaq:NEOL) today announced the presentation of initial safety data from a Phase I study of cintredekin besudotox in the treatment of newly diagnosed malignant glioma patients at the 55th Annual Meeting of the Congress of Neurolo ... http://www.transworldnews.com/NewsStory.aspx?storyid=3679 http://www.transworldnews.com/NewsStory.aspx?storyid=3679 Mon, 10 Oct 2005 06:00:00 GMT NeoPharm Announces Cintredekin Besudotox Poster Presentation at 55th Annual Meeting of the Congress of Neurological Surgeons (CNS) . http://www.transworldnews.com/NewsStory.aspx?storyid=3680 http://www.transworldnews.com/NewsStory.aspx?storyid=3680 Tue, 04 Oct 2005 06:00:00 GMT NeoPharm Announces PRECISE Trial Update . http://www.transworldnews.com/NewsStory.aspx?storyid=7874 http://www.transworldnews.com/NewsStory.aspx?storyid=7874 Mon, 03 Oct 2005 06:05:00 GMT NeoPharm Announces Shelf Registration Update; Shelf Registration Extended 3 Years Under New Securities Regulations . http://www.transworldnews.com/NewsStory.aspx?storyid=7873 http://www.transworldnews.com/NewsStory.aspx?storyid=7873 Mon, 03 Oct 2005 06:00:00 GMT NeoPharm Announces LEP-ETU Project Update . http://www.transworldnews.com/NewsStory.aspx?storyid=7875 http://www.transworldnews.com/NewsStory.aspx?storyid=7875 Thu, 29 Sep 2005 06:00:00 GMT NeoPharm, Inc. Updates Phase I/II Median Survival Data and PRECISE Trial . http://www.transworldnews.com/NewsStory.aspx?storyid=7876 http://www.transworldnews.com/NewsStory.aspx?storyid=7876 Tue, 27 Sep 2005 06:00:00 GMT NeoPharm to Present at UBS 2005 Global Life Sciences Conference . http://www.transworldnews.com/NewsStory.aspx?storyid=7877 http://www.transworldnews.com/NewsStory.aspx?storyid=7877 Tue, 20 Sep 2005 06:00:00 GMT NeoPharm Announces FDA Acceptance of Interim Efficacy Analysis Proposal for PRECISE Trial; -- Interim Efficacy Analysis to Occur at 160 Deaths . http://www.transworldnews.com/NewsStory.aspx?storyid=7878 http://www.transworldnews.com/NewsStory.aspx?storyid=7878 Wed, 24 Aug 2005 06:00:00 GMT NeoPharm Announces Second Quarter and First Half 2005 Financial Results . http://www.transworldnews.com/NewsStory.aspx?storyid=7879 http://www.transworldnews.com/NewsStory.aspx?storyid=7879 Fri, 29 Jul 2005 06:00:00 GMT NeoPharm Sets Conference Call and Webcast for Second Quarter 2005 Corporate Results . http://www.transworldnews.com/NewsStory.aspx?storyid=7880 http://www.transworldnews.com/NewsStory.aspx?storyid=7880 Fri, 15 Jul 2005 06:00:00 GMT NeoPharm, Inc. Announces Precise Trial Update . http://www.transworldnews.com/NewsStory.aspx?storyid=7881 http://www.transworldnews.com/NewsStory.aspx?storyid=7881 Mon, 27 Jun 2005 06:00:00 GMT NeoPharm Announces Delivery of Its First Customized NeoPhectin Formulation . http://www.transworldnews.com/NewsStory.aspx?storyid=7882 http://www.transworldnews.com/NewsStory.aspx?storyid=7882 Thu, 23 Jun 2005 06:00:00 GMT